Clinical Trial Update: Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating topical BMX-010 for acne vulgaris was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• BMX-010

Snippet

Sponsor: BioMimetix JV, LLC | Conditions: Acne Vulgaris | Phase 2 | Status: TERMINATED | Results posted: 2023-09-21